CELG

Celgene News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Celgene Corporation CELG NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 108.24 0.00 0.00 0.00 108.24 20:00:00
more quote information »

Recent News

Date Time Source Heading
12/16/201907:30GLOBENexImmune Appoints Sol Barer as Chairman of the Board of..
11/21/201906:21PRNUSAmgen Completes Acquisition Of Otezla® (apremilast)
11/20/201916:18BWCelgene Announces Plans to Transfer Listing of Celgene’s..
11/20/201914:09BWCELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR..
11/19/201911:16PRNUSThermo Fisher Scientific Set to Join S&P 100; ServiceNow to..
11/18/201917:10GLOBEExelon Corporation to Join the NASDAQ-100 Index Beginning..
11/15/201917:39DJNFTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla..
11/15/201908:22DJNCelgene Gets CHMP Positive Opinion for Revlimid/Rituximab..
11/15/201907:30BWCelgene Receives CHMP Positive Opinion for REVLIMID®..
11/12/201922:28PRNCASkyhawk Therapeutics annonce une deuxième entente de..
11/12/201909:00PRNCASkyhawk Therapeutics Announces a Second Multi-Target..
11/08/201913:30DJNAcceleron Pharma Shares Gain Ground After FDA Approves..
11/08/201913:20DJNFDA Approves Celgene's and Acceleron's Reblozyl to Treat..
11/08/201912:33BWFDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment..
11/06/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
11/06/201909:06BWCelgene to Present New & Updated Data on Key Hematology..
11/04/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
11/04/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
11/04/201916:16EDGARStatement of Changes in Beneficial Ownership (4)
11/04/201916:16EDGARStatement of Changes in Beneficial Ownership (4)
11/04/201916:10EDGARStatement of Changes in Beneficial Ownership (4)
10/31/201916:05EDGARQuarterly Report (10-q)
10/31/201907:37EDGARCurrent Report Filing (8-k)
10/31/201907:30BWCelgene Reports Third Quarter 2019 Operating and Financial..
10/16/201906:00BWCelgene & the Multiple Sclerosis Association of America Take..
9/20/201907:30BWCelgene Corporation Names Second Round of Celgene Cancer..
9/19/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
9/12/201916:30BWCelgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as..
9/11/201912:24DJNSwiss Biotech Anokion Raises $40 Million in Series B Round
9/09/201907:30BWData from Ozanimod Clinical Development Program in Relapsing..
8/27/201903:02DJNCelgene, Bristol Clear Way For Merger -- WSJ
8/26/201911:14DJNAmgen to Buy Celgene's Otezla for $13.4 Billion--Update
8/26/201907:49DJNAmgen to Buy Celgene's Otezla for $13.4 Billion -- Update
8/26/201907:31EDGARCurrent Report Filing (8-k)
8/26/201907:14DJNAmgen to Buy Celgene's Otezla for $13.4 Billion
8/26/201906:30PRNUSAmgen To Acquire Otezla® For $13.4 Billion In Cash, Or..
8/21/201908:45NNWRecord Revenues, Milestone Achievements Indicate Strength,..
8/16/201911:14DJNFDA Grants Approval to Celgene's Impact for Bone Marrow..
8/16/201910:30BWU.S. FDA Approves INREBIC® (Fedratinib) as First New..
8/05/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
7/30/201916:12EDGARQuarterly Report (10-q)
7/30/201908:43DJNSecond-Quarter Revenue at Celgene Surpasses Wall Street..
7/30/201907:43EDGARCurrent Report Filing (8-k)
7/30/201907:30BWCelgene Reports Second Quarter 2019 Operating and Financial..
7/29/201910:10BWBristol-Myers Squibb Announces European Commission Approval..
7/26/201913:24GLOBEHach Rose Schirripa & Cheverie LLP Announces $55 Million..
7/25/201908:13DJNBristol-Myers Squibb Reports Higher Profit, Revises..
7/24/201907:30BWCelgene & the Multiple Sclerosis Association of America..
7/23/201916:00GLOBEJounce Therapeutics Announces Update on Strategic..
7/19/201914:47DJNCelgene Says FDA Approves Otezla for Oral Ulcers in Behcet's..
See more news about this stock »
Your Recent History
NASDAQ
CELG
Celgene
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200714 13:00:11